Boundless Bio, Inc. (BOLD)
Boundless Bio, Inc., a clinical-stage oncology company, focuses on developing innovative cancer therapies aimed at addressing the significant unmet needs of patients with oncogene amplified tumors. Their core strategy involves targeting extrachromosomal DNA (ecDNA). The company's lead product candidate, BBI-355, an orally administered inhibitor of checkpoint kinase 1 (CHK1), is currently in Phase 1/2 clinical trials for patients suffering from oncogene amplified cancers. Additionally, Boundless Bio is advancing BBI-825, another oral inhibitor, this one targeting ribonucleotide reductase (RNR), also in Phase 1/2 clinical development for cancer patients exhibiting resistance gene amplifications. A third initiative, the ecDTx 3 program, is designed to target a kinesin crucial for the cellular segregation mechanism of ecDNA. Incorporated in 2018, the company originally operated as Pretzel Therapeutics, Inc. before adopting the name Boundless Bio, Inc. in July 2019. Its headquarters are situated in San Diego, California.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Boundless Bio, Inc.
NASDAQ:BOLDHealthcare · Biotechnology
-0.40%$2.47
AH$2.47+0.00%vs close
Mkt Cap$56.19M
Float19.4M
O/S22.75M
Vol
$ Vol
RVOL
Inst Own68.2%
SI4.1%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$58.2M
Total Assets$157.06M
Free Cash Flow-$47.21M
Debt & Equity
Debt 33%
Equity 67%
Total Debt$49.03M
Total Equity$98.65M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in BOLD's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$157.06M
Liabilities$58.41M
Accounts Receivable$0
Accounts Payable$1.49M
Inventory$0
PP&E (Net)$46.88M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - | - |
| Cost of Revenue | $1.25M | $1.09M | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | -$1.25M | -$1.09M | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | - | - | - | - | - | - | - | - |
| Research and Development | $44.84M | $55.27M | $42.64M | $37.16M | $19.28M | $104.37M | $75.9M | $48.77M |
| Selling, General, and Administrative | $18.71M | $18M | $12.16M | $9.31M | $6.02M | $30M | $17.27M | $11.28M |
| Other | -$1.25M | -$1.09M | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $62.3M | $72.18M | $54.8M | $46.47M | $25.3M | $134.37M | $93.18M | $60.05M |
| Operating Income (EBIT) | -$63.55M | -$73.27M | -$54.8M | -$46.47M | -$25.3M | -$134.37M | -$93.18M | -$60.05M |
| Operating Margin | - | - | - | - | - | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $5.36M | $7.89M | $5.28M | $668K | $96K | $0 | $0 | $0 |
| Other Income (Expense) | $5.36M | $7.9M | $5.36M | $568K | $91K | $5.55M | $693K | $378K |
| Income Before Tax (EBT) | -$58.2M | -$65.36M | -$49.43M | -$45.9M | -$25.21M | -$128.82M | -$92.48M | -$59.67M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | -$2.25M | $378K |
| Net Income | -$58.2M | -$65.36M | -$49.43M | -$45.9M | -$25.21M | -$128.82M | -$90.24M | -$59.67M |
| Net Income Margin | - | - | - | - | - | - | - | - |
| Supplementary Data | ||||||||
| EPS | -2.60 | -3.85 | -2.22 | -2.06 | -1.13 | -2.93 | -3.40 | -5.59 |
| Diluted EPS | -2.60 | -3.85 | -2.22 | -2.06 | -1.13 | -2.93 | -3.40 | -5.59 |
| Weighted Average OS | 22.36M | 16.98M | 22.24M | 22.24M | 22.24M | 44.03M | 26.58M | 10.67M |
| EBITDA | -$56.95M | -$64.28M | -$48.48M | -$44.96M | -$24.53M | -$121.36M | -$88.74M | -$58.09M |
| EBITDA Margin | - | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and Cash Equivalents | $17.87M | $26.59M | $23.71M | $10.95M | $34.29M | $144.35M | $38.97M | $36.36M |
| Short-Term Investments | $89.71M | $125.53M | $97.05M | $55.77M | $38.74M | $269.96M | $94.64M | $68.52M |
| Cash and Short-Term Investments | $107.58M | $152.11M | $120.75M | $66.72M | $73.03M | $414.31M | $133.6M | $104.88M |
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $2.03M | $2.28M | $3.45M | $1.32M | $1.54M | $5.46M | $3.4M | $3.55M |
| Total Current Assets | $109.61M | $154.39M | $124.2M | $68.04M | $74.57M | $419.77M | $137.01M | $108.44M |
| Long-Term Assets | ||||||||
| Property, Plant & Equipment Net | $46.88M | $51.36M | $4.58M | $7.73M | $3.1M | $32.1M | $24.37M | $18.94M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $3.63M | $3.63M | $3.63M |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $8M | $8M | $8M |
| Long-Term Investments | $0 | $0 | $560K | $0 | $34.99M | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $2.62M | $2.56M | $1.21M |
| Other Long-Term Assets | $573K | $659K | $555K | $1.07M | $1.07M | $6.43M | $3.09M | $1.84M |
| Total Long-Term Assets | $47.45M | $52.02M | $5.69M | $8.79M | $39.15M | $52.78M | $41.65M | $33.62M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $157.06M | $206.41M | $129.89M | $76.83M | $113.72M | $472.56M | $178.66M | $142.06M |
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts Payable | $1.49M | $1.27M | $2.22M | $1.4M | $1.07M | $8.12M | $3.85M | $2.42M |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $2.35M | $4.64M | $265K |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $7.72M | $5.56M | $2.97M |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $7.72M | $5.56M | $2.97M |
| Other Current Liabilities | $2.64M | $2.78M | $2.9M | $2.55M | $1.51M | $5.67M | $3.65M | $6.9M |
| Total Current Liabilities | $12.54M | $8.13M | $9.36M | $7.73M | $3.87M | $23.85M | $17.71M | $12.56M |
| Long-Term Liabilities | ||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $4.72M | $2.54M | $2.49M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $4.72M | $2.54M | $1.78M |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $1.01M | $1.01M | $3.26M |
| Other Long-Term Liabilities | $0 | $0 | $247.62M | $147.95M | $148.04M | $0 | $0 | $0 |
| Total Long-Term Liabilities | $45.87M | $47.63M | $247.62M | $150.8M | $148.04M | $10.45M | $6.08M | $7.52M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | -$4.5M | -$1.73M | $2.6M |
| Total Liabilities | $58.41M | $55.77M | $256.98M | $158.53M | $151.91M | $29.8M | $22.06M | $22.69M |
| Stockholders' Equity | ||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $2K | $2K | $0 | $2K | $2K | $300M | $300M | $300M |
| Retained Earnings | -$259.67M | -$201.47M | -$136.11M | -$86.67M | -$40.77M | -$319.47M | -$190.65M | -$100.41M |
| Comprehensive Income & Other | $64K | $121K | $40K | -$398K | -$175K | -$60K | -$80K | -$29K |
| Other Stockholders' Equity | $358.32M | $352.11M | $9.03M | $4.98M | $2.58M | $462.22M | $47.25M | -$80.22M |
| Total Equity | $98.65M | $150.64M | -$127.08M | -$81.7M | -$38.19M | $442.75M | $156.6M | $119.37M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $157.06M | $206.41M | $129.89M | $76.83M | $113.72M | $472.56M | $178.66M | $142.06M |
| Supplementary Data | ||||||||
| Total Debt | $49.03M | $47.63M | $2.19M | $5.18M | $377K | $7.07M | $7.18M | $2.75M |
| Net Debt | $31.17M | $21.05M | -$21.51M | -$5.77M | -$33.91M | -$137.28M | -$31.79M | -$33.61M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Operating Activities | ||||||||
| Net Income | -$58.2M | -$65.36M | -$49.43M | -$45.9M | -$25.21M | -$128.82M | -$90.24M | -$59.67M |
| Depreciation & Amortization | $1.25M | $1.09M | $957K | $942K | $682K | $7.46M | $3.75M | $1.58M |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $2.25M | -$95.21M |
| Stock-Based Compensation | $6.13M | $7.52M | $3.34M | $2.29M | $1.16M | $0 | $6.88M | $2M |
| Changes in Working Capital: | ||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $1.63M | $775K | $0 | $1.91M | $0 | $4.08M | $686K | -$671K |
| Other Working Capital | $1.83M | -$2.45M | -$799K | -$1.04M | -$837K | $272.54M | $22.73M | $671K |
| Total Working Capital Change | $3.46M | -$1.68M | -$799K | $866K | -$837K | $276.62M | $23.42M | $95.21M |
| Other Non-Cash Items | $698K | -$2.4M | -$915K | $2.21M | $959K | -$279.73M | -$30.57M | $7.07M |
| Net Cash from Operating | -$46.66M | -$60.84M | -$46.85M | -$39.6M | -$23.25M | -$107.98M | -$84.51M | -$49.02M |
| Investing Activities | ||||||||
| Capital Expenditures | -$546K | -$2.54M | -$633K | -$1.07M | -$2.03M | -$11.61M | -$7.55M | -$16.65M |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$174.9M | -$208.47M | -$160.12M | -$42.6M | -$77.49M | -$382.02M | -$152.71M | -$104.04M |
| Sales of Investments | $213.24M | $184.9M | $122.5M | $59.8M | $20.24M | $208.59M | $126.83M | $58.62M |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $16K |
| Net Cash from Investing | $37.8M | -$26.1M | -$38.26M | $16.13M | -$59.28M | -$185.05M | -$33.44M | -$62.05M |
| Financing Activities | ||||||||
| Debt Repaid | - | - | - | - | - | - | - | - |
| Common Stock Issuance | $141K | $93M | $0 | $126K | $0 | $14.6M | $39.1M | $75.21M |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | -$144.35M | -$38.97M | -$36.36M |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | -$3.18M | -$1.77M | $0 | $208K | $398.46M | $120.55M | $75.36M |
| Net Cash from Financing | $141K | $89.82M | $97.9M | $126K | $105.53M | $398.46M | $120.55M | $75.36M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$8.72M | $2.88M | $12.78M | -$23.34M | $22.99M | $105.44M | $2.61M | -$35.7M |
| Supplementary Data | ||||||||
| Operating Cash Flow | -$46.66M | -$60.84M | -$46.85M | -$39.6M | -$23.25M | -$107.98M | -$84.51M | -$49.02M |
| Capital Expenditure | -$546K | -$2.54M | -$633K | -$1.07M | -$2.03M | -$11.61M | -$7.55M | -$16.65M |
| Free Cash Flow | -$47.21M | -$63.38M | -$47.49M | -$40.66M | -$25.28M | -$119.59M | -$92.06M | -$65.67M |
| Cash at Beginning | $27.15M | $24.27M | $11.48M | $34.29M | $11.83M | $38.91M | $36.36M | $72.06M |
| Cash at End | $18.43M | $27.15M | $24.27M | $10.95M | $34.82M | $144.35M | $38.97M | $36.36M |